Janice Ohta

 

Janice is a seasoned executive with over 17 years experience in the biotechnology industry. Most recently, Janice has focused on her involvement or board positions with a few non-profit organizations including the Pasadena Bioscience Center and the Harbor/UCLA Research & Education Institute. In addition, she accepts various consulting assignments ranging from strategic planning to financial management to early stage venture capital. Janice retired from ten years at Amgen, Inc. where she was Director, Business Planning and Analysis. In this position she was responsible for Finance in Product Development (with over $300 million in expense worldwide), International Project Management, Strategic Planning and Portfolio Management, as well as involvement in acquisitions and licensing activities. Janice's Project Management group was responsible for managing over 23 INDs and NDAs in more than 6 different therapeutic areas.

Janice began her career conducting research projects for academic institutions including the Salk Institute and the UCSD Medical Center. She then went to work for Hybritech, Inc. developing antibody-based diagnostics. She later joined Chimertech, Inc. as Project Manager. For this start-up company focused on developing genetically engineered antibodies as therapeutics for cancer and AIDS targets, she oversaw the all business development aspects of the firm including strategic and financial planning, market analysis, development of collaborations and acquisition of funding.

Janice holds a B.A. in psychology, biology and organic chemistry from University of California, San Diego and an M.B.A. from the Anderson School at the University of California, Los Angeles.

 

Back to Board of Directors